
Courtney Breen
analystFemale0.0Global Dominance: 0.00%
Courtney Breen is a financial analyst known for her insights in the pharmaceutical sector, particularly regarding drug pricing and market trends. She has provided critical analysis on the financial implications of pricing strategies announced by major pharmaceutical companies, including Pfizer. Breen's research often focuses on how pricing changes affect both the companies' financial health and the broader healthcare landscape.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Analyst Courtney Breen noted that Gilead is likely the largest beneficiary of the recent pharmaceutical deals.
Trump, nine pharmaceutical companies strike deal to cut pricesStabroek News·
Guyana· 2025-12-20
Bernstein analyst Courtney Breen commented on Pfizer’s announced price cuts.
Pfizer to cut drug prices in exchange for tariff relief, Trump saysThe Globe and Mail·
Canada· 2025-09-30





